Boston Financial Mangement LLC Has $31.05 Million Holdings in Waters Co. (NYSE:WAT)

Boston Financial Mangement LLC lessened its position in shares of Waters Co. (NYSE:WAT) by 0.5% in the fourth quarter, HoldingsChannel.com reports. The fund owned 83,707 shares of the medical instruments supplier’s stock after selling 451 shares during the period. Boston Financial Mangement LLC’s holdings in Waters were worth $31,054,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in the company. Bleakley Financial Group LLC acquired a new stake in shares of Waters in the 3rd quarter valued at $216,000. Blue Trust Inc. raised its stake in Waters by 170.6% during the third quarter. Blue Trust Inc. now owns 322 shares of the medical instruments supplier’s stock worth $116,000 after acquiring an additional 203 shares in the last quarter. Allspring Global Investments Holdings LLC lifted its holdings in shares of Waters by 65.6% in the third quarter. Allspring Global Investments Holdings LLC now owns 4,711 shares of the medical instruments supplier’s stock worth $1,695,000 after acquiring an additional 1,867 shares during the last quarter. Sequoia Financial Advisors LLC boosted its stake in shares of Waters by 30.9% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 1,471 shares of the medical instruments supplier’s stock valued at $529,000 after purchasing an additional 347 shares in the last quarter. Finally, Waldron Private Wealth LLC acquired a new position in Waters during the 3rd quarter worth approximately $217,000. Institutional investors and hedge funds own 94.01% of the company’s stock.

Waters Trading Up 0.3 %

NYSE WAT opened at $377.30 on Thursday. The company has a market cap of $22.40 billion, a price-to-earnings ratio of 35.23, a P/E/G ratio of 3.74 and a beta of 1.01. The business has a 50 day moving average price of $388.97 and a 200-day moving average price of $365.18. The company has a quick ratio of 0.65, a current ratio of 0.94 and a debt-to-equity ratio of 1.14. Waters Co. has a 52 week low of $279.24 and a 52 week high of $423.56.

Waters (NYSE:WAT) last posted its earnings results on Wednesday, February 12th. The medical instruments supplier reported $4.10 earnings per share for the quarter, topping analysts’ consensus estimates of $4.02 by $0.08. Waters had a net margin of 21.56% and a return on equity of 46.31%. As a group, equities analysts expect that Waters Co. will post 12.86 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research analysts have recently issued reports on WAT shares. JPMorgan Chase & Co. upped their price target on shares of Waters from $340.00 to $380.00 and gave the stock a “neutral” rating in a report on Monday, November 4th. StockNews.com upgraded Waters from a “hold” rating to a “buy” rating in a report on Monday. Deutsche Bank Aktiengesellschaft raised their price target on shares of Waters from $310.00 to $325.00 and gave the company a “hold” rating in a research note on Monday, November 4th. TD Cowen raised their target price on Waters from $363.00 to $410.00 and gave the stock a “hold” rating in a research report on Monday, November 4th. Finally, Scotiabank upgraded Waters from a “sector perform” rating to a “sector outperform” rating and raised their price objective for the stock from $430.00 to $450.00 in a research report on Thursday, February 13th. Ten equities research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $390.40.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.